NFKB1 and neoplasm: In the last few years, there have been studies showing that lidocaine may have anti-tumor effects, in which DNA demethylation, interactions with mRNAs, the direct inhibition of tumor cell proliferation and migration, Src and NfkB inhibition, and antiangiogenic effects are involved [5,6].